Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
about
Topical cyclosporine A therapy for dry eye syndromesPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse modelInhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13Epithelial-immune cell interaction in dry eye.Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimenA mouse dry eye model induced by topical administration of benzalkonium chloride.Trehalose: an intriguing disaccharide with potential for medical application in ophthalmology.The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery.Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways.Desiccating stress induces CD4+ T-cell-mediated Sjögren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-γAltered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence.Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye diseaseEffects of estrogen replacement therapy on apoptosis and vascular endothelial growth factor expression in ocular surface epithelial cells: An experimental study.Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit modelA Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.Aqueous Tear Deficiency Increases Conjunctival Interferon-γ (IFN-γ) Expression and Goblet Cell Loss.The effect of topical cyclosporine 0.05% on dry eye after cataract surgery.Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eyeEffect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease.Loss of parasympathetic innervation leads to sustained expression of pro-inflammatory genes in the rat lacrimal gland.T helper cytokines in dry eye diseaseA semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye.Dry eye disease as an inflammatory disorder.TFOS DEWS II Tear Film Report.The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model.Current and prospective treatment options for Sjögren's syndrome.New approaches in Sjögren's syndrome therapy.Topical cyclosporine a for mustard gas induced ocular surface disorders.Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13.Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression.Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.Anti-Inflammatory and Anti-Apoptotic Effects of Acer Palmatum Thumb. Extract, KIOM-2015EW, in a Hyperosmolar-Stress-Induced In Vitro Dry Eye Model.Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.What We Have Learned From Animal Models of Dry Eye.Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye DiseaseConjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1
P2860
Q24201139-095C7C65-28E1-4A10-AED1-4570B515D4AFQ24635932-6B5A1033-80AD-4AA6-9417-7D1FC5565B40Q28469505-12D660A6-259C-44E7-BEF0-542F942C4B77Q33850150-890C7FD4-FE77-4D94-98CB-5AAAF2C0774FQ34028408-B7D31DD0-865E-4C0A-8454-64A34CD822A2Q34076208-957AC3D7-DE32-4CCC-8579-07436F2182FDQ34538059-7C401084-63BC-4519-B5EC-734BDAF085ADQ35009029-62AEC88F-A98F-422C-88E0-36BD71E413D4Q35095724-1238EEE9-7968-4D57-AAB1-DEAF4A92A11CQ35221255-B9968EEE-4694-497B-9CBC-43DAC095453BQ35235692-188CD027-D623-4BE7-9959-4C2741EBFB6BQ35356313-912404D9-BFC0-4FE4-855E-969EBEBF0AF5Q35570541-77F21393-747D-4D6A-A3CB-4AE8F096EFCEQ35638200-CA689E48-FCA9-42EA-8E27-F0D73870D654Q35907009-84C81C3C-2D27-414C-BD09-1E849383BBFAQ35924238-3070136F-FD1C-4FA0-B396-1F33B038E9F6Q36182937-7ACB9F72-31FF-4D68-9564-26168043EB54Q36342984-755E59D7-C703-4702-A67D-ED19A5947DCAQ36345503-AEF71BFE-DAA1-4303-A732-2C9C20253D90Q36872338-74EE8671-1BE5-4813-8CFC-5B36DBCF6C20Q37070035-AAA32098-B4DF-4672-A3A0-0B6716BF5480Q37126861-15165BCF-906C-4E3B-8710-F68D92A36044Q37258291-C8BBAE77-FA95-4642-8F3E-6AD851406F87Q37374838-C32FD5AD-E04E-42AD-8212-F49BE67D89EDQ37719148-B5DE70F3-1737-4333-B158-D56059D5A12BQ37756166-D42CD6A8-27B8-40D0-89FE-2CB0EFBD3A2CQ38652990-96F4C52A-4FC5-4F1B-BCAD-9E1C814533DEQ39820355-47EB54A9-85E6-40D1-BC1C-E44CBE8DB20EQ40076686-088F3C53-BB2C-408C-80B6-2220AE40A83CQ40238844-49414B96-928E-475D-95E6-D6922E8CC829Q40444348-E8F2405C-880B-45F5-8ED2-5A3BAC132C93Q42173370-3B7CEE17-AD86-4B9C-A2B8-C75AF75E14C4Q42925094-CCB8075F-B1E6-4B93-99CD-FDDA72C168F2Q46194450-F9F4AB52-6F47-45E9-9F10-A9D0B8D92C0AQ53081062-910F0293-7395-4AB7-941B-BF490AF13158Q53558849-785F6349-E76A-4516-A359-D030FFA53460Q53999120-5566DCBC-38B5-4DFD-8CF2-B8C82519BEE3Q57479273-4F542CC2-B501-4865-AE5E-44436336D61EQ58122088-DE2450DD-AEE3-4E8F-B0D7-F7ADBF6067C7
P2860
Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Topical cyclosporine inhibits ...... ne keratoconjunctivitis sicca.
@en
Topical cyclosporine inhibits ...... ne keratoconjunctivitis sicca.
@nl
type
label
Topical cyclosporine inhibits ...... ne keratoconjunctivitis sicca.
@en
Topical cyclosporine inhibits ...... ne keratoconjunctivitis sicca.
@nl
prefLabel
Topical cyclosporine inhibits ...... ne keratoconjunctivitis sicca.
@en
Topical cyclosporine inhibits ...... ne keratoconjunctivitis sicca.
@nl
P2093
P1433
P1476
Topical cyclosporine inhibits ...... ne keratoconjunctivitis sicca.
@en
P2093
Bradley Strong
Michael E Stern
Stephen C Pflugfelder
William Farley
P356
10.1097/01.ICO.0000133994.22392.47
P577
2005-01-01T00:00:00Z